← Back to Search

Increased Protein Intake (Eggs) for Cancer Recovery

N/A
Recruiting
Led By Vera Mazurak, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline at 8 weeks
Awards & highlights

Summary

This trial will assess if eating ≥2 eggs a day can help restore nutritional status, improve immune function & quality of life in cancer patients post-treatment.

Who is the study for?
This trial is for adults over 18 who've finished platinum chemotherapy for cancer, can eat on their own, and are willing to follow the study plan. It's not for those allergic to eggs, fed by tubes or IV nutrition, with brain cancer or conditions affecting food consumption or nutrient metabolism.Check my eligibility
What is being tested?
The study tests if adding at least two eggs daily to the diet of cancer patients post-treatment can improve protein intake, immune function, and quality of life. Participants are randomly assigned to start this egg-enriched diet either immediately or after four weeks.See study design
What are the potential side effects?
Since the intervention involves common dietary items like eggs, side effects may be minimal but could include potential allergic reactions in individuals sensitive to eggs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline at 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline at 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in mean cumulative protein intake between the two groups at 8 weeks.
Difference in mean cumulative protein intake within a group at 8 weeks for each group.
Secondary outcome measures
Change in Body weight
Change in Energy Intake
Change in Nutritional status and Symptom severity.
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Early InterventionExperimental Treatment1 Intervention
Participants are expected to begin intervention immediately after the completion of treatment for a period of 8 weeks.
Group II: Delayed InterventionExperimental Treatment1 Intervention
Participants are expected to begin intervention 4 weeks after the completion of the treatment, for a period of 4 weeks (weeks 5-8).

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
901 Previous Clinical Trials
387,460 Total Patients Enrolled
Egg Farmers of CanadaUNKNOWN
2 Previous Clinical Trials
175 Total Patients Enrolled
Vera Mazurak, PhDPrincipal InvestigatorUniversity of Alberta
2 Previous Clinical Trials
49 Total Patients Enrolled
~24 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top